Session Information
2007 Midyear Clinical Meeting
Debates in Therapeutics 2007
Track: Educational Session
Program Code: 221-L01
Date: Monday, December 3, 2007
Time: 2:00 p.m. - 5:00 p.m.
Location:
Lido 3001-3/3101-3MEETING PLANNING ASSOCIATE:
Dr. Melinda Neuhauser, PharmD, Clinical Pharmacy Specialist, Infectious Diseases, VA Pharmacy Benefits Management SHG
MODERATOR:
Dr. Melinda Neuhauser, PharmD, Clinical Pharmacy Specialist, Infectious Diseases, VA Pharmacy Benefits Management SHG
PRESENTERS:
Dr. Kevin Garey, PharmD, MS, Associate Professor, University of Houston
Dr. Robert Owens, Jr., PharmD, Co-Director, Antimicrobial Stewardship, Maine Medical Center, Depart of Clinical Pharm & ID
Jean Nappi, PharmD, Director, Residency Programs, Medical University of South Carolina
David Parra, Clinical Pharmacy Specialist in Cardiology, Veerans Affairs Medical Center
Paul Milligan, Clinical Pharmacist, Barnes Jewish Hospital
Dr. Ann Wittkowsky, PharmD, CACP, Director, Anticoagulation Services, University of Washington Medical Center
John Lewin III, PharmD, Clinical Pharmacy Specialist, Neurosciences Critical Care Unit, Johns Hopkins Hospital
Steven E. Pass, Pharm.D., FCCM,, Clinical Associate Professor, Surgical ICU Clinical Specialist, University of Houston College of Pharmacy,
LEARNING OBJECTIVES
- Discuss why therapeutics controversy may occur.
- Identify four therapeutic areas wehre controversy exists.
- Describe the pro and con side of selected therapeutic issues.